![Christopher Degnan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Degnan
Finansdirektör/CFO på
UROGEN PHARMA LTD.
Förmögenhet: 87 187 $ per 2026-07-31
Profil
Christopher Degnan currently works at UroGen Pharma Ltd., as Chief Financial & Accounting Officer from 2024.
Mr. Degnan also formerly worked at AstraZeneca PLC, as Senior Finance Director from 2004 to 2014, Endo International Plc, as Chief Financial Officer from 2016 to 2018, Endo Pharmaceuticals, Inc., as Chief Financial Officer & Vice President-Finance, Verrica Pharmaceuticals, Inc., as Chief Financial & Accounting Officer from 2018 to 2019, and Galera Therapeutics, Inc., as Chief Financial & Accounting Officer.
Mr. Degnan received his undergraduate degree from the University of Notre Dame.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-01-31 | 2 280 ( 0 % ) | 87 187 $ | 2026-07-31 |
Aktiva positioner av Christopher Degnan
| Företag | Position | Start |
|---|---|---|
| UROGEN PHARMA LTD. | Finansdirektör/CFO | 2024-10-08 |
Tidigare kända positioner av Christopher Degnan
| Företag | Position | Slut |
|---|---|---|
| GALERA T COM USD0. | Finansdirektör/CFO | 2024-08-31 |
| VERRICA PHARMACEUTICALS INC. | Finansdirektör/CFO | 2019-10-07 |
| ENDO INTERNATIONAL PLC | Finansdirektör/CFO | 2018-03-01 |
| ASTRAZENECA PLC | Finansdirektör/CFO | 2014-11-01 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Finansdirektör/CFO | - |
Christopher Degnans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
72
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galera Therapeutics, Inc.
 Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
Endo International Plc
 Endo International Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures immunology, urology, hepatology, generics & sterile injectables therapeutics products | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
Verrica Pharmaceuticals, Inc.
 Verrica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
